NEW YORK, Feb 27 (Reuters) - U.S. drugmaker Wyeth (WYE.N), which is slated to merge with Pfizer Inc later this year, has granted chief executive Bernard Poussot $10.25 million as a 2009 long-term incentive award and approved multi-million dollar awards to other senior executives.
